Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza Virus Vaccine”

Showing 20 of 0 results

Not applicableLooking for participantsNCT06907667
What this trial is testing

Study of the Impact of Time of Vaccination on Response to Influenza Vaccine in Patients With Chronic Renal Failure

Who this might be right for
Vaccination; Infection
Centre Hospitalier Universitaire de Nice 735
Post-approval studies (Phase 4)Study completedNCT01069367
What this trial is testing

Open-label, Uncontrolled Postmarketing Study of Cell-derived A/H1N1 Influenza HA Vaccine in Japanese Elderly Subjects

Who this might be right for
Swine-Origin Influenza A H1N1 Virus
Novartis Vaccines 100
Not applicableStudy completedNCT01192737
What this trial is testing

"COhort Study on A/H1N1 FLU During PREGnancy"

Who this might be right for
InfluenzaPregnancy
Institut National de la Santé Et de la Recherche Médicale, France 919
Not applicableStudy completedNCT02872311
What this trial is testing

Open-Label Influenza Vaccine Evaluation

Who this might be right for
Immune Response
Marshfield Clinic Research Foundation 179
Large-scale testing (Phase 3)Study completedNCT01057771
What this trial is testing

Meditation and Exercise for Prevention of Acute Respiratory Infection

Who this might be right for
Acute Respiratory Infection
University of Wisconsin, Madison 154
Large-scale testing (Phase 3)Ended earlyNCT04544267
What this trial is testing

Study on a High-Dose Quadrivalent Influenza Vaccine Compared With Standard-Dose Quadrivalent Influenza Vaccine in Children 6 Months Through 35 Months of Age

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT07113392
What this trial is testing

Evaluate the Safety, Efficacy and Pharmacokinetics of Suraxavir Marboxil for Suspension

Who this might be right for
Influenza
Jiangxi Kvvit Pharmaceutical Co., Ltd. 144
Not applicableStudy completedNCT04615936
What this trial is testing

Nasal Photodisinfection COVID-19 Proof of Concept Study

Who this might be right for
COVID-19Corona Virus InfectionSARS-CoV 2
Sunnybrook Health Sciences Centre 45
Post-approval studies (Phase 4)Study completedNCT03163342
What this trial is testing

Immune Response Following Seasonal Influenza Vaccination

Who this might be right for
Influenza
Altimmune, Inc. 20
Not applicableStudy completedNCT03481270
What this trial is testing

The Oakland Men's Health Disparities Study

Who this might be right for
BehaviorCardiovascular Risk FactorInfluenza
Stanford University 1,374
Not applicableStudy completedNCT00639418
What this trial is testing

Describe Pediatric Influenza Vaccine Coverage

Who this might be right for
Healthy
MedImmune LLC 147,494
Not applicableStudy completedNCT03641690
What this trial is testing

Serum and Bronchoalveolar Inflammatory Parameters in Patients With Severe Adult Respiratory Distress Syndrome

Who this might be right for
H1N1 Influenza
Centre Hospitalier Universitaire, Amiens 97
Large-scale testing (Phase 3)Looking for participantsNCT06653569
What this trial is testing

Efficacy of Baloxavir Against Influenza in Hospitalized Patients: The INFLUENT Study (INpatients inFLUENza Treatment)

Who this might be right for
Influenza Disease; Flu
Dre Pauline Vetter 484
Not applicableStudy completedNCT01149382
What this trial is testing

Immune Response to Influenza Vaccine in Islet Cell Transplant Recipients

Who this might be right for
Transplant
University of Alberta 61
Testing effectiveness (Phase 2)Study completedNCT04961541
What this trial is testing

Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine

Who this might be right for
SARS-CoV InfectionCovid19
Novavax 637
Post-approval studies (Phase 4)Study completedNCT03688620
What this trial is testing

Enhanced Safety Surveillance of GlaxoSmithKline's (GSK's) Quadrivalent Seasonal Influenza Vaccines During the 2018/19 Influenza Season

Who this might be right for
Influenza, Human
GlaxoSmithKline 1,060
Large-scale testing (Phase 3)Study completedNCT01209780
What this trial is testing

Safety and Immunogenicity of Trivalent Subunit Inactivated Flu Vaccine Administered to Healthy Children and Adolescents 3 to 17 Years of Age

Who this might be right for
Seasonal Influenza
Novartis Vaccines 3,116
Testing effectiveness (Phase 2)Study completedNCT00946179
What this trial is testing

Study of Influenza Vaccine (Split Virion, Inactivated) Northern Hemisphere 2009-2010 Formulation

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 130
Post-approval studies (Phase 4)Study completedNCT03378479
What this trial is testing

Posaconazole for the Prevention of Influenza-associated Aspergillosis in Critically Ill Patients

Who this might be right for
Aspergillosis; Pulmonary, Invasive (Etiology)
Universitaire Ziekenhuizen KU Leuven 88
Large-scale testing (Phase 3)Study completedNCT03615482
What this trial is testing

Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)

Who this might be right for
Pneumococcal Infections
Merck Sharp & Dohme LLC 1,200
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation